Form 4 for KYNB KYNTRA BIO, INC.
Accepted 2024-06-13 00:00:00 ET · period of report 2024-06-12 · accession 0001415889-24-016677 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-13 | 2024-06-12 | KYNB | Adib Deyaa | Chief Medical Off | P - Purchase | $1.17 | +22.1K | 82.1K | +37% | +$25.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-12 | P | A | 22,123 | $1.17 | 82,123 | D | — | — |